Study Details
Full Title
A Double-blind, Placebo-Controlled, Randomized Withdrawal Trial to Evaluate the
Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy
(Narcolepsy Type 1)
Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy
(Narcolepsy Type 1)
Principal Investigator
Aatif
Husain
Protocol Number
PRO00119132
NCT ID
NCT07363720
Phase
III
Enrollment Status
Open to Enrollment